GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Purchase Of Investment

Pharmosa Biopharm (ROCO:6875) Purchase Of Investment : NT$275.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm Purchase Of Investment?

Pharmosa Biopharm's purchase of investment for the three months ended in Mar. 2025 was NT$275.0 Mil. It means Pharmosa Biopharm spent NT$-275.0 Mil on purchasing investments. Pharmosa Biopharm's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2025 was NT$275.0 Mil.

Compared with last quarter (NT$0.0 Mil in Dec. 2024 ), Pharmosa Biopharm spent less money on purchasing investments in Mar. 2025 (NT$275.0 Mil).

Pharmosa Biopharm Purchase Of Investment Historical Data

The historical data trend for Pharmosa Biopharm's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm Purchase Of Investment Chart

Pharmosa Biopharm Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial - - - - -869.00

Pharmosa Biopharm Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 275.00

Pharmosa Biopharm Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$275.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmosa Biopharm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Purchase Of Investment
Comparable Companies
TPE:1734 TPE:1760 TPE:6657 ROCO:4167 ROCO:7759 ROCO:7832 ROCO:4157 ROCO:4178 TPE:6949 ROCO:6945 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 508, Sec. 7, Zhongxiao E. Road, 11F / 11F-1, Nangang District, Taipei, TWN
Website
https://www.pharmosa.com.tw
Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology. Geographically, the company generates almost all of its revenue from the USA, and a small portion from Taiwan.

Pharmosa Biopharm Headlines

No Headlines